Latest Share Chat

REMOVE ADS

Immupharma Share News (IMM)

Immupharma Information

Share Price Information for Immupharma (IMM)

Share Price is delayed by 15 minutes

Get Live Data

4.40 0.00 (0.00%)

Bid:

4.395

Ask:

5.50

Spread: 1.105 (25.142%)

Market Cap: £27.45m

Last checked at -

Intraday Immupharma Share Chart

REMOVE ADS

Immupharma News

ImmuPharma Poised For Phase III Trials Of Lupuzor As Loss As Expected

ImmuPharma Forms European Research Team As Part Of Peptides Drive

ImmuPharma Granted New US Patent For Nucant Cancer Treatments

LONDON (Alliance News) - ImmuPharma PLC said Monday that it had been granted a US patent for a new "optically pure" version of its Nucant family of ca...

Immupharma gains new patents for Nucant treatments

Drug developer Immupharma has improved the patent protection of its Nucant cancer treatments. Immupharma said the US Patent and Trademark Office has ...

ImmuPharma's patient approach disappoints

Losses from AIM-listed biotech ImmuPharma were less than expected, with the company working hard to commercialise its Lupuzor lupus treatment via phas...

ImmuPharma Losses Widen As It Accelerates Research And Development

LONDON (Alliance News) - Specialist drug discovery and development company ImmuPharma PLC Wednesday said it losses widened in 2013, as its invests in ...

ImmuPharma Narrows Losses, Developing Lupus Treatment

ImmuPharma reports half-year loss

ImmuPharma's shares fell in Friday morning trading as the company reported a half-year loss in line with last year. Losses for the first six months o...